Your browser doesn't support javascript.
loading
Use of metformin in patients who require intravascular administration of a contrast agent.
Rokicka, Dominika; Wróbel, Marta; Stoltny, Dorota; Strojek, Krzysztof.
Afiliação
  • Rokicka D; Department of Internal Medicine, Diabetology and Cardiometabolic Disorders, Faculty of Medical Sciences Zabrze; Medical University of Silesia, Katowice, Poland. dominika.rokicka@poczta.fm.
  • Wróbel M; Department of Internal Medicine, Diabetology and Cardiometabolic Disorders, Faculty of Medical Sciences Zabrze; Medical University of Silesia, Katowice, Poland.
  • Stoltny D; Department of Internal Medicine, Diabetology and Cardiometabolic Disorders, Faculty of Medical Sciences Zabrze; Medical University of Silesia, Katowice, Poland.
  • Strojek K; Department of Internal Medicine, Diabetology and Cardiometabolic Disorders, Faculty of Medical Sciences Zabrze; Medical University of Silesia, Katowice, Poland.
Endokrynol Pol ; 73(6): 913-916, 2022.
Article em En | MEDLINE | ID: mdl-36519659
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Resistência à Insulina / Diabetes Mellitus Tipo 2 / Metformina Tipo de estudo: Guideline Limite: Female / Humans Idioma: En Revista: Endokrynol Pol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Resistência à Insulina / Diabetes Mellitus Tipo 2 / Metformina Tipo de estudo: Guideline Limite: Female / Humans Idioma: En Revista: Endokrynol Pol Ano de publicação: 2022 Tipo de documento: Article